Los avances científicos como derecho humano de tercera generación en tiempos de pandemia
The pandemic caused by the Covid-19 virus has pose a threat to humanity, forcing the entire world to implement measures of distancing and social isolation and has been a terrible blow to the planet’s economy and public health. Large pharmaceutical companies around the world financed, on many occasio...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
2022
|
Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8348671 |
Source: | Jurídicas CUC, ISSN 1692-3030, Vol. 18, Nº. 1, 2022 (Ejemplar dedicado a: Jurídicas CUC 2022; 217–240), pags. 53-84 |
Tags: |
Add Tag
No Tags: Be the first to tag this record
|
id |
dialnet-ar-18-ART0001518524
|
---|---|
record_format |
dialnet
|
institution |
Dialnet
|
collection |
Dialnet AR
|
source |
Jurídicas CUC, ISSN 1692-3030, Vol. 18, Nº. 1, 2022 (Ejemplar dedicado a: Jurídicas CUC 2022; 217–240), pags. 53-84
|
language |
Spanish
|
description |
The pandemic caused by the Covid-19 virus has pose a threat to humanity, forcing the entire world to implement measures of distancing and social isolation and has been a terrible blow to the planet’s economy and public health. Large pharmaceutical companies around the world financed, on many occasions, with public money, were braided in a runaway race to get a vaccine that could return the planet to the hoped normality, leaving their coffers full. This paper analyzes the consequences of preventing the release of the patent for this vaccine in relation to the human right to use advances in science and technology. Using a qualitative methodology, with a descriptive, correlational and explanatory scope, based on a review of the literature, the opposition that occurs between the rights of peoples to receive the Covid-19 vaccine, as part of the right to use, is evidenced. of the advances of science and technology in its capacity as a third generation human right, and the interests of large pharmaceutical companies and private business conglomerates, in the light of Law, ethics and public health, discerning on a controversial issue that has humanity in suspense. It is concluded that what is at stake goes beyond economic interests, since those who own and maintain ownership of patents will have an advantage in terms of geopolitics and, incidentally, greater control over biopolitics.
|
format |
Article
|
author |
Ramírez Castiblanco, Maria Cristina
|
spellingShingle |
Ramírez Castiblanco, Maria Cristina
Los avances científicos como derecho humano de tercera generación en tiempos de pandemia |
author_facet |
Ramírez Castiblanco, Maria Cristina
|
author_sort |
Ramírez Castiblanco, Maria Cristina
|
title |
Los avances científicos como derecho humano de tercera generación en tiempos de pandemia
|
title_short |
Los avances científicos como derecho humano de tercera generación en tiempos de pandemia
|
title_full |
Los avances científicos como derecho humano de tercera generación en tiempos de pandemia
|
title_fullStr |
Los avances científicos como derecho humano de tercera generación en tiempos de pandemia
|
title_full_unstemmed |
Los avances científicos como derecho humano de tercera generación en tiempos de pandemia
|
title_sort |
los avances científicos como derecho humano de tercera generación en tiempos de pandemia
|
publishDate |
2022
|
url |
https://dialnet.unirioja.es/servlet/oaiart?codigo=8348671
|
_version_ |
1727672889850724352
|
spelling |
dialnet-ar-18-ART00015185242022-03-17Los avances científicos como derecho humano de tercera generación en tiempos de pandemiaRamírez Castiblanco, Maria CristinaThe pandemic caused by the Covid-19 virus has pose a threat to humanity, forcing the entire world to implement measures of distancing and social isolation and has been a terrible blow to the planet’s economy and public health. Large pharmaceutical companies around the world financed, on many occasions, with public money, were braided in a runaway race to get a vaccine that could return the planet to the hoped normality, leaving their coffers full. This paper analyzes the consequences of preventing the release of the patent for this vaccine in relation to the human right to use advances in science and technology. Using a qualitative methodology, with a descriptive, correlational and explanatory scope, based on a review of the literature, the opposition that occurs between the rights of peoples to receive the Covid-19 vaccine, as part of the right to use, is evidenced. of the advances of science and technology in its capacity as a third generation human right, and the interests of large pharmaceutical companies and private business conglomerates, in the light of Law, ethics and public health, discerning on a controversial issue that has humanity in suspense. It is concluded that what is at stake goes beyond economic interests, since those who own and maintain ownership of patents will have an advantage in terms of geopolitics and, incidentally, greater control over biopolitics.La pandemia ocasionada por el virus Covid-19 ha puesto en jaque a la humanidad obligando al mundo entero a implementar medidas de distanciamiento y aislamiento social afectando la economía del planeta y la salud pública. Las grandes farmacéuticas financiadas, en muchas ocasiones, con dinero público se envolvieron en una carrera desbocada por conseguir una vacuna que pudiera regresar al planeta a la añorada normalidad dejando de paso sus arcas llenas. En el presente trabajo se analizan las consecuencias de impedir la liberación de la patente de esta vacuna con relación al derecho humano al uso de los avances de las ciencias y la tecnología. Empleando una metodología cualitativa, con un alcance descriptivo, basada en la revisión sistemática, bibliográfica y documental de la literatura, se evidencia la contraposición que se presenta entre los derechos de los pueblos a recibir la vacuna contra el Covid-19, como parte del derecho al uso de los avances de la ciencia y la tecnología en su calidad de derecho humano de tercera generación, y los intereses de las grandes empresas farmacéuticas y conglomerados empresariales privados, a la luz del Derecho, la ética y la salud pública, discerniendo sobre un tema controvertido que tiene en vilo a la humanidad. Se concluye que lo que está en juego va más allá de los intereses económicos, pues quienes posean y mantengan la propiedad de las patentes tendrán ventaja en términos de geopolítica y, de paso, mayor control sobre la biopolítica.2022text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8348671(Revista) ISSN 1692-3030Jurídicas CUC, ISSN 1692-3030, Vol. 18, Nº. 1, 2022 (Ejemplar dedicado a: Jurídicas CUC 2022; 217–240), pags. 53-84spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
|